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quantitative functional parameters such as tissue 
cellularity, vascular permeability/perfusion, and 
hypoxia. Despite limitations imposed by manu‑
facturers, some cardiology referral centers per‑
form off ‑label MRI with an excellent short‑ and 
medium ‑term safety profile, providing interpreta‑
ble images that frequently influence clinical care.3
A 57 ‑year ‑old woman after implantation of 
conventional (non–MRI ‑compatible) cardiac re‑
synchronization therapy device (CRT ‑D) in 2014 
for secondary prevention of sudden cardiac death 
and heart failure with reduced ejection fraction 
was referred for MRI due to progressive spastic 
paraparesis of the lower extremities since Janu‑
ary 2017. Due to contraindications to MRI related 
to noncompatible implant, a spinal CT scan was 
performed as a method of choice, which showed 
moderate degenerative changes and discopathy 
at all spinal levels (FIGURE 1A and 1B). However, 
The use of magnetic resonance imaging (MRI) 
in patients with conventional pacemakers and 
cardioverter defibrillators has been limited by 
manufacturers due to safety reasons. Because of 
the complexity of issues involved with these devic‑
es, MRI should only be considered when alterna‑
tive imaging modalities will not provide sufficient 
information.1 The use of MRI in radiotherapy and 
surgery planning has been rapidly gaining pop‑
ularity.2 MRI provides high ‑quality imaging and 
superior soft ‑tissue contrast in comparison with 
computed tomography (CT), allowing a better def‑
inition of organ and tissue abnormalities. The lack 
of additional radiation exposure provides another 
attractive feature for intratreatment imaging. In 
addition, diffusion ‑weighted, dynamic contrast‑
‑enhanced, intrinsic susceptibility ‑weighted, and 
other MRI techniques allow a more advanced 
characterization of cancer biology by providing 
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FIGURE 1 Imaging of the spine; A – contrast ‑enhanced computed tomography, sagittal view; B – contrast ‑enhanced 
computed tomography, transverse view; arrow 1, vertebral canal at the T1–T2 level; arrow 2, endocardial lead artifacts
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the pathology leading to symptoms has not been 
identified. The patient was referred for MRI af‑
ter appropriate reprogramming of the CRT ‑D. 
The MRI of the thoracic segment revealed a lesion 
at the T1–T2 level of the spinal canal (FIGURE 1C ‑1F). 
Oval smooth contours with a wide base adhered to 
the meninges and showed intense, homogeneous 
contrast enhancement. Radiologically, the tumor 
revealed features of a meningioma, which filled 
the majority of the spinal canal lumen and signifi‑
cantly compressed the spinal cord. A minor tumor 
of similar type was revealed in the posterior part 
of the spinal canal at the T10 level. After the scan, 
the CRT ‑D device check was performed. The de‑
vice worked properly and neither inappropriate 
shock nor inappropriate pacing were observed. 
The patient was referred for a neurosurgical oper‑
ation. After surgical removal of the tumor and re‑
habilitation, the neurological state of the patient 
has improved considerably. At 1 ‑month follow ‑up, 
no significant changes were observed in CRT ‑D 
parameters. A histological examination confirmed 
meningioma.
In conclusion, off ‑label MRI in a patient with 
non–MRI ‑compatible device performed under 
a strict protocol demonstrated excellent short‑ 
and medium ‑term overall safety, while providing 
interpretable images that influenced clinical care.
FIGURE 1 C – 
T2 ‑weighted magnetic 
resonance image, 
sagittal view; D – T2‑
‑weighted magnetic 
resonance image, 
transverse view; E – 
T1 ‑weighted magnetic 
resonance image with 
contrast, sagittal view; 
F – T1 ‑weighted 
magnetic resonance 
image with contrast, 
transverse view; 
arrow 3, a tumor at the 
T1–T2 level; arrow 4, 
spinal cord; arrow 5, 
spinal cord compressed 
by tumor
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